By joining Bio-Techne, you’ll join a company with a powerful and positive purpose of enabling cutting-edge research in Life Sciences and Clinical Diagnostics. Bio-Techne, and all of its brands, provides tools for researchers to further treat and prevent disease worldwide.
Location: Shanghai
Reports to: Vice President, Asia-Pacific
Position Overview
Lead the comprehensive commercial strategy for Bio-Techne’s Life Science portfolio across Greater China, focusing on Protein Science, Cell & Gene Therapy (CGT), Spatial Multi-Omics, and Diagnostic Development. Integrate high-value reagents (e.g., ELISA/antibodies/recombinant proteins), precision instruments (e.g., automation platforms, spatial biology systems), and diagnostic raw materials to deliver end-to-end customer solutions. Direct hybrid (direct + distribution) teams to deeply engage strategic accounts’ R&D pipelines, ensuring sustainable growth.
Key Responsibilities
1. Strategic Growth & Portfolio Leadership
Solution Selling: Champion integrated platform solutions (e.g., antibody development + automated detection systems, spatial transcriptomics reagents + imaging platforms) targeting top-tier research institutes, CGT companies, and IVD developers.
Emerging Market Capture: Develop Go-to-Market (GTM) strategies for Spatial Biology and Organoid/Cell Therapy segments, establishing KOL-driven lighthouse accounts.
Diagnostics Expansion: Collaborate with Diagnostics Division to penetrate IVD raw materials (antibodies/antigens/controls) in local pharma/medtech firms, supporting regulatory needs.
2. Key Account & Channel Excellence
Strategic Account Ownership:
Personally manage Top 30 accounts (e.g., WuXi group, CAS elite labs), addressing customer pain points (e.g., target validation, process QC) with tailored reagent-instrument bundles.
Deliver co-development support (e.g., custom protein development, application training) for strategic partners.
Distribution Network Optimization:
Build effective distribution system to allow easy-to-buy for end user
Manage regional distributors for high-value reagents, prioritizing technically capable partners and enforcing pricing compliance.
Drive direct sales for premium instruments (e.g., Lunaphore, ProteinSimple) via demo unit placements and KOL engagement.
3. Team & Operational Leadership
Build Technical Sales Force:
Recruit domain experts (proteomics, molecular diagnostics, cell therapy) to enhance pre-sales consulting capabilities.
Establish pre-sales/post-sales collaboration to ensure customer success for complex systems (e.g., Simple Western, MultiOmyx).
Data-Driven Operations:
Track customer R&D stage demands (preclinical/IND/commercial) via CRM to forecast purchasing cycles.
Monitor reagent-instrument cross-sell ratio to maximize wallet share.
4. Cross-Functional Collaboration
R&D Alignment: Capture China-specific needs (e.g., target-specific antibodies, NMPA-compliant raw materials) for APAC R&D prioritization.
Marketing Synergy:
Lead advanced technical workshops (e.g., protein quantification, spatial single-cell analysis) to strengthen technical branding.
Develop vertical-focused case studies (e.g., CAR-T QC solutions, CDx antibody development).
Qualifications
Mandatory Requirements
Education: Master’s degree or higher in Life Sciences, Biochemistry, or related field; MBA preferred.
Experience:
Minimum 15+ years in life science sales leadership, with both:
High-value reagents: Antibodies/proteins/cell factors/diagnostic raw materials (annual portfolio ≥ RMB 200M).
Premium instruments: Automation systems (e.g., Western Blot alternatives), omics platforms (spatial multi-omics, single-cell), or bioreactors.
Proven IVD raw materials market experience: Understanding of IVD customer procurement cycles, regulatory QC, and compliance (GMP/ISO 13485).
Distribution network management: Successfully overseen ≥30 regional distributors with conflict-resolution expertise.
Track record and Achievements:
Achieved ≥20% YoY growth for premium instrument product lines.
Closed ≥3 enterprise-level solution deals (≥RMB 5M/order) with multinational pharma/CXO firms.
Core Competencies
Technical Acumen: Ability to interpret experimental data (e.g., WB/IHC results) and propose optimization strategies; deep knowledge of biologics development workflows.
Regulatory Awareness: Expertise in IVD raw material regulations (NMPA, GMP) and import policies for research equipment.
Leadership: Ability to navigate matrixed global-local dynamics and build high-performance cross-cultural teams.
Preferred Qualifications
Experience commercializing Spatial Biology technologies (Visium, Xenium, MERFISH).
Familiarity with cell therapy QC workflows (viability, vector titer, residual testing).
Native Mandarin fluency + professional English proficiency (for global strategy alignment).
Willingness to travel ≥50% (including international).
Why Join Bio-Techne:
- We offer competitive wages along with extensive benefits for employees and their families.
- We invest in our employees’ financial futures through retirement programs and an employee stock purchase plan.
- We help our employees develop their careers through mentorship, promotional opportunities, training and development, internship programs, and more.
- We offer an international and diverse working environment, enriched by employee resource groups; volunteer and charity events; and employee events that build a culture of caring and belonging.
- We foster a culture of empowerment and innovation, where employees feel valued and encouraged to bring their new ideas to the table.
Bio-Techne is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.
To protect the interests of all, Bio-Techne will not accept unsolicited resumes from any source other than a candidate application. Any unsolicited resumes sent to Bio-Techne will be considered Bio-Techne property.
Top Skills
What We Do
Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and cell and gene therapy workflow solutions including T-Cell activation technologies. Bio-Techne’s portfolio also includes protein analysis solutions, sold under the ProteinSimple brand name, that offer researchers efficient and streamlined options for automated Western blot and multiplexed ELISA workflow. These reagent and protein analysis solutions are sold to biomedical researchers, as well as clinical research laboratories, and constitute the Protein Sciences Segment.
Bio-Techne also develops and manufactures diagnostic products including FDA-regulated controls, calibrators, blood gas and clinical chemistry controls, and other reagents for OEM and clinical customers. Bio-Techne’s genomic tools include advanced tissue-based in situ hybridization assays (ISH) for research and clinical use, sold under the ACD brand, as well as a portfolio of clinical molecular diagnostic oncology assays including the ExoDx®Prostate (IntelliScore) test (EPI) for prostate cancer diagnosis. These diagnostic and genomic products comprise Bio-Techne’s Diagnostics and Genomics Segment.
Bio-Techne products are integral components of scientific investigations into biological processes and molecular diagnostics, revealing the nature, diagnosis, etiology and progression of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $714 million in net sales in fiscal 2019 and has over 2,200 employees worldwide.
